Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status
Glioblastoma (GBM) with oligodendroglioma component (GBMO) is a newly described GBM subtype in the 2007 World Health Organization classification. However, its biological and genetic characteristics are largely unknown. We investigated the clinicopathological and molecular features of 34 GBMOs and c...
Main Authors: | Jae Kyung Myung, Hwa jin Cho, Hanna Kim, Chul-Kee Park, Se Hoon Lee, Seung Hong Choi, Peom Park, Jung Min Yoon, Sung-Hye Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-12-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523314001077 |
Similar Items
-
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
by: Ruichao Chai, et al.
Published: (2021-02-01) -
XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
by: Nguyen Quoc Khanh Le, et al.
Published: (2020-09-01) -
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
by: Josefine Radke, et al.
Published: (2019-06-01) -
The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation
by: Francesco Marchi, et al.
Published: (2020-01-01) -
Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation
by: Fatih Incekara, et al.
Published: (2020-05-01)